Curis | CRIS - Ingresos Por Ventas





Ventas Cambio Fecha
Alaunos Therapeutics USD 2K 2K 2025-03
Amgen USD 10.1B 1.48B 2026-06
AstraZeneca USD 15.38B 90M 2026-06
Bayer EUR 10.87B 2.54B 2026-06
Bristol-Myers Squibb USD 12.97B 1.48B 2026-06
CSL USD 8.33B 4.79B 2025-12
Curis USD 1.14M 1.41M 2025-12
Eli Lilly USD 22.97B 3.17B 2026-06
Exelixis USD 628.69M 17.89M 2026-06
Gilead Sciences USD 7.8B 800M 2026-06
GlaxoSmithKline GBP 8.41B 781M 2026-06
Incyte USD 1.67B 400M 2026-06
Merck USD 16.6B 310M 2026-06
Novartis USD 14.41B 1.3B 2026-06
Pfizer USD 15.03B 530M 2026-06
Roche Holding CHF 30.36B 14.71B 2026-06
Sanofi EUR 11.95B 710M 2026-06
Takeda JPY 1.22T 130B 2026-06
TG Therapeutics USD 240.34M 45.54M 2026-06
Verastem USD 18.67M 1.14M 2026-03